🔗 Share this article

Treasury head Reeves has revealed she is preparing "targeted action to tackle cost of living issues" in next month's financial statement.

Speaking to media outlets, she emphasized that lowering inflation is a shared duty of both the administration and the central bank.

The United Kingdom's price growth is forecast to be the highest among the G7 industrialized countries this calendar year and the following year.

Potential Energy Cost Interventions

Sources suggest the administration could intervene to bring down energy bills, such as by reducing the current 5% rate of value-added tax charged on energy supplies.

An additional approach is to lower some of the policy costs presently included in household expenses.

Fiscal Constraints and Expert Expectations

The government will obtain the latest assessment from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will show how much scope there is for such measures.

The consensus from most economists is that Reeves will have to declare higher taxes or budget cuts in order to adhere to her declared fiscal targets.

Earlier on the same day, analysis suggested there was a twenty-two billion pound gap for the Treasury chief to resolve, which is at the lower end of projections.

"It is a collective job between the central bank and the administration to further reduce some of the drivers of inflation," the Chancellor informed reporters in Washington, at the conferences of the IMF and global financial institution.

Tax Pledges and International Concerns

While much of the attention has been on likely tax increases, the Treasury chief said the latest information from the OBR had not altered her pledge to campaign commitments not to raise tax levels on income tax, VAT or social security contributions.

She blamed an "unpredictable world" with rising international and trade issues for the Budget tax moves, likely to be focused on those "with the broadest shoulders."

Global Trade Tensions

Commenting on concerns about the United Kingdom's commercial links with China she said: "Our security interests invariably come first."

Recent statement by Chinese authorities to increase export controls on rare earths and other materials that are essential for advanced tech manufacturing led American leader Donald Trump to suggest an further 100% import tax on goods from the Asian country, increasing the possibility of an all-out commercial conflict between the two largest economies.

The American finance chief labeled China's move "economic coercion" and "a international production control attempt."

Questioned on considering the US offer to join its conflict with China, the Chancellor said she was "very concerned" by China's actions and urged the Beijing authorities "not to put up barriers and limit trade."

She said the action was "harmful for the international commerce and creates additional headwinds."

"It is my opinion there are fields where we need to confront Chinese policies, but there are also valuable chances to sell into Chinese markets, including financial services and other areas of the economy. We've got to get that balance right."

The chancellor also stated she was working with G7 counterparts "regarding our own critical minerals plan, so that we are less reliant."

NHS Medicine Costs and Funding

The Chancellor also recognized that the cost the National Health Service spends on pharmaceuticals could increase as a consequence of current negotiations with the US government and its pharmaceutical firms, in return for reduced taxes and capital.

Some of the world's largest drug companies have said lately that they are either delaying or canceling operations in the UK, with some attributing the low prices they are getting.

Last month, the government science advisor said the price the health service pays for drugs would need to increase to stop companies and pharmaceutical investment leaving the UK.

The Chancellor stated to the BBC: "We have seen due to the cost structure, that drug testing, innovative medicines have not been provided in the UK in the manner that they are in other EU nations."

"Our aim is to ensure that patients receiving treatment from the National Health Service are able to obtain the top essential drugs in the world. And so we are examining all of that, and... aiming to attract additional funding into Britain."